Exalenz Bioscience
Exalenz Bioscience
Exalenz Bioscience (pronounced: ex-a-lenz bio-science) is a medical technology company that specializes in the development and commercialization of advanced diagnostic systems for gastrointestinal (GI) and liver diseases.
Etymology
The name "Exalenz" is a portmanteau of "exa", a prefix in the International System of Units denoting 10^18, and "lens", symbolizing the company's focus on providing a detailed view into the body's internal systems.
History
Exalenz Bioscience was founded in 2006, with its headquarters located in Modi'in, Israel. The company's primary focus is on the development of non-invasive diagnostic tools for gastrointestinal diseases and liver diseases, with a particular emphasis on breath tests.
Products
Exalenz Bioscience's flagship product is the BreathID® System, a non-invasive, point-of-care diagnostic system that uses breath testing to detect and monitor various GI and liver conditions. The system is based on the principle of Breath Testing, a diagnostic method that measures the presence of certain gases in a patient's breath to diagnose and monitor diseases.
Related Terms
- Gastrointestinal Diseases: A group of diseases that affect the gastrointestinal tract, which includes the esophagus, stomach, small intestine, and large intestine.
- Liver Diseases: A category of diseases and disorders that cause liver damage or dysfunction.
- Breath Testing: A non-invasive diagnostic method that measures the presence of certain gases in a patient's breath to diagnose and monitor diseases.
External links
- Medical encyclopedia article on Exalenz Bioscience
- Wikipedia's article - Exalenz Bioscience
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski